Related Experiment Videos
Macrophage colony stimulating factor involvement in uremic patients
Y Le Meur1, P Fixe, J C Aldigier
1Service de Néphrologie et d'Hémodialyse, Hôpital Universitaire Dupuytren, France.
Kidney International
|September 1, 1996
Summary
Elevated macrophage colony stimulating factor (M-CSF) in chronic renal failure (CRF) patients suggests a role in immune dysregulation. This may prime monocytes for activation, contributing to the immunodeficiency seen in kidney disease.
Area of Science:
- Immunology
- Nephrology
- Cytokine Network
Background:
- Patients with chronic renal failure (CRF) exhibit complex immune alterations, including chronic monocytic activation.
- Macrophage colony stimulating factor (M-CSF) is crucial for monocyte/macrophage function and cytokine production.
Purpose of the Study:
- To investigate the role of M-CSF in the immunological disorders associated with CRF.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure M-CSF serum levels.
- Correlations were analyzed between M-CSF levels, renal insufficiency, lymphocyte counts, and erythropoietin treatment.
Main Results:
- M-CSF serum levels were significantly higher in CRF patients (including hemodialysis and CAPD) compared to controls.
- M-CSF levels did not correlate with the degree of renal insufficiency.
- In hemodialysis patients, M-CSF inversely correlated with lymphocyte count and was higher in anemic patients treated with erythropoietin.
Conclusions:
- Elevated M-CSF in CRF may contribute to immune system alterations by maintaining primed monocytes/macrophages.
- This chronic priming could lead to enhanced activation by secondary stimuli, impacting uremic immunodeficiency.